phenobarbital has been researched along with Biliary Atresia in 8 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
Biliary Atresia: Progressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE.
Excerpt | Relevance | Reference |
---|---|---|
"The purpose of this study was to re-evaluate the accuracy of phenobarbital-enhanced hepatobiliary scintigraphy in differentiating biliary atresia from other causes of neonatal cholestasis." | 7.79 | Phenobarbital-enhanced hepatobiliary scintigraphy in the diagnosis of biliary atresia: two decades of experience at a tertiary center. ( Ghelani, S; Kwatra, N; Majd, M; Mohan, P; Narayanan, S; Shalaby-Rana, E, 2013) |
" Group 1 (n = 48), group 2 (n = 29), and group 3 (n = 18) received phenobarbital at the dosage of 5 mg/kg/day for at least 5 days, less than 5 mg/kg/day or less than 5 days, and no premedication, respectively." | 5.32 | The effect of phenobarbital on the accuracy of technetium-99m diisopropyl iminodiacetic acid hepatobiliary scintigraphy in differentiating biliary atresia from neonatal hepatitis syndrome. ( Charearnrad, P; Chongsrisawat, V; Poovorawan, Y; Tepmongkol, S, 2003) |
"The purpose of this study was to re-evaluate the accuracy of phenobarbital-enhanced hepatobiliary scintigraphy in differentiating biliary atresia from other causes of neonatal cholestasis." | 3.79 | Phenobarbital-enhanced hepatobiliary scintigraphy in the diagnosis of biliary atresia: two decades of experience at a tertiary center. ( Ghelani, S; Kwatra, N; Majd, M; Mohan, P; Narayanan, S; Shalaby-Rana, E, 2013) |
"Phenobarbital is a long-acting barbiturate metabolized in the liver by the cytochrome p450 3a4 system." | 1.33 | Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient. ( Bristow, LJ; Chang, IF; Goss, JA; Karpen, SJ; Quirós-Tejeira, RE, 2005) |
" Group 1 (n = 48), group 2 (n = 29), and group 3 (n = 18) received phenobarbital at the dosage of 5 mg/kg/day for at least 5 days, less than 5 mg/kg/day or less than 5 days, and no premedication, respectively." | 1.32 | The effect of phenobarbital on the accuracy of technetium-99m diisopropyl iminodiacetic acid hepatobiliary scintigraphy in differentiating biliary atresia from neonatal hepatitis syndrome. ( Charearnrad, P; Chongsrisawat, V; Poovorawan, Y; Tepmongkol, S, 2003) |
"Phenobarbital was administered to 22 patients before imaging." | 1.29 | Utility of Tc-99m mebrofenin scintigraphy in the assessment of infantile jaundice. ( Ben-Haim, S; Brown, BP; Johnson, J; Kao, SC; Seabold, JE; Tran, D, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kwatra, N | 1 |
Shalaby-Rana, E | 1 |
Narayanan, S | 1 |
Mohan, P | 1 |
Ghelani, S | 1 |
Majd, M | 1 |
Charearnrad, P | 1 |
Chongsrisawat, V | 1 |
Tepmongkol, S | 1 |
Poovorawan, Y | 1 |
Quirós-Tejeira, RE | 1 |
Chang, IF | 1 |
Bristow, LJ | 1 |
Karpen, SJ | 1 |
Goss, JA | 1 |
Sevilla, A | 1 |
Howman-Giles, R | 1 |
Saleh, H | 1 |
Trpezanovski, J | 1 |
Concannon, R | 1 |
Williams, K | 1 |
Chung, D | 1 |
Uren, R | 1 |
Ben-Haim, S | 1 |
Seabold, JE | 1 |
Kao, SC | 1 |
Johnson, J | 1 |
Tran, D | 1 |
Brown, BP | 1 |
Lin, WY | 1 |
Lin, CC | 1 |
Changlai, SP | 1 |
Shen, YY | 1 |
Wang, SJ | 1 |
Golladay, ES | 1 |
Slezak, JW | 1 |
Seibert, JJ | 1 |
Rivera-Echegoyen, M | 1 |
Ramírez-Mayans, JA | 1 |
Casaubón-Garcín, P | 1 |
Núñez-Malaver, CE | 1 |
Avila-Ramírez, E | 1 |
Sosa-Martínez, C | 1 |
8 other studies available for phenobarbital and Biliary Atresia
Article | Year |
---|---|
Phenobarbital-enhanced hepatobiliary scintigraphy in the diagnosis of biliary atresia: two decades of experience at a tertiary center.
Topics: Biliary Atresia; Causality; Cholestasis; District of Columbia; Female; Humans; Image Enhancement; In | 2013 |
The effect of phenobarbital on the accuracy of technetium-99m diisopropyl iminodiacetic acid hepatobiliary scintigraphy in differentiating biliary atresia from neonatal hepatitis syndrome.
Topics: Biliary Atresia; Excitatory Amino Acid Antagonists; Female; Hepatitis; Humans; Infant; Infant, Newbo | 2003 |
Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient.
Topics: Biliary Atresia; Half-Life; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Male; P | 2005 |
Hepatobiliary scintigraphy with SPECT in infancy.
Topics: Biliary Atresia; Female; Humans; Infant; Infant, Newborn; Liver Diseases; Male; Phenobarbital; Retro | 2007 |
Utility of Tc-99m mebrofenin scintigraphy in the assessment of infantile jaundice.
Topics: Aniline Compounds; Biliary Atresia; Cholestasis, Intrahepatic; Female; Glycine; Hepatitis; Humans; I | 1995 |
Comparison technetium of Tc-99m disofenin cholescintigraphy with ultrasonography in the differentiation of biliary atresia from other forms of neonatal jaundice.
Topics: Biliary Atresia; Cholestyramine Resin; Diagnosis, Differential; Female; Humans; Imino Acids; Infant; | 1997 |
Intractable cholangitis due to conduit obstruction.
Topics: Anti-Bacterial Agents; Biliary Atresia; Child; Cholangitis; Clinical Protocols; Humans; Methylpredni | 1990 |
[Neonatal cholestatic syndrome: use of phenobarbital in the gammagram of the bile ducts].
Topics: Bile Ducts; Biliary Atresia; Bilirubin; Diagnosis, Differential; Female; Humans; Imino Acids; Infant | 1988 |